卓和药业1.1类创新中药九味止咳口服液获批上市，AZ、安进、三生等新药临床获受理

医药经济报02-21

1、1类创新药九味止咳口服液获批2月21日，国家药品监督管理局批准了卓和药业集团股份有限公司申报的中药1.1类创新药九味止咳口服液上市。据卓和药业公开资料显示，该公司拥有药物合成、药物制剂、药物分析和知识产权管理等多个学科专业化的研发创新能力，研发中心在研项目涉及抗风湿、免疫调节、抗结核、肿瘤、感染、心脑血管等疾病领域。2、三生制药1类小分子新药申报临床2月21日，据CDE官网显示，三生制药1类...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2413443984?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-21 20:02","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2413443984","market":"us","top_or_hot":-1,"title":"卓和药业1.1类创新中药九味止咳口服液获批上市，AZ、安进、三生等新药临床获受理","media":"医药经济报","content":"<div>\n<p>1、1类创新药九味止咳口服液获批2月21日，国家药品监督管理局批准了卓和药业集团股份有限公司申报的中药1.1类创新药九味止咳口服液上市。据卓和药业公开资料显示，该公司拥有药物合成、药物制剂、药物分析和知识产权管理等多个学科专业化的研发创新能力，研发中心在研项目涉及抗风湿、免疫调节、抗结核、肿瘤、感染、心脑血管等疾病领域。2、三生制药1类小分子新药申报临床2月21日，据CDE官网显示，三生制药1类...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022120054487a8f447&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>卓和药业1.1类创新中药九味止咳口服液获批上市，AZ、安进、三生等新药临床获受理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n卓和药业1.1类创新中药九味止咳口服液获批上市，AZ、安进、三生等新药临床获受理\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-21 20:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022120054487a8f447&s=b><strong>医药经济报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1、1类创新药九味止咳口服液获批2月21日，国家药品监督管理局批准了卓和药业集团股份有限公司申报的中药1.1类创新药九味止咳口服液上市。据卓和药业公开资料显示，该公司拥有药物合成、药物制剂、药物分析和知识产权管理等多个学科专业化的研发创新能力，研发中心在研项目涉及抗风湿、免疫调节、抗结核、肿瘤、感染、心脑血管等疾病领域。2、三生制药1类小分子新药申报临床2月21日，据CDE官网显示，三生制药1类...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022120054487a8f447&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2242652126.USD","symbol_name":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022120054487a8f447&s=b","article_id":"2413443984","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022120054487a8f447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2413443984","pubTimestamp":1708516928,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"Tremelimumab已于今年10月获FDA批准上市，用于与度伐利尤单抗联用一线治疗肝癌。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","BK4588":"碎股","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4581":"高盛持仓","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","AZ":"A2Z Smart Technologies","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","AMGN":"安进","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0058720904.USD":"联博国际健康护理基金A","BK4187":"航天航空与国防","LU0122379950.USD":"贝莱德世界健康科学A2","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4139":"生物科技","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4566":"资本集团"},"translate_title":"Zhuohe Pharmaceutical's 1.1 innovative Chinese medicine Jiuwei Zhike Oral Liquid was approved for marketing, and new drugs such as AZ, Anjin and Sansheng were clinically accepted","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZ":1,"AMGN":1},"content_text":"1、1类创新药九味止咳口服液获批2月21日，国家药品监督管理局批准了卓和药业集团股份有限公司申报的中药1.1类创新药九味止咳口服液上市。据卓和药业公开资料显示，该公司拥有药物合成、药物制剂、药物分析和知识产权管理等多个学科专业化的研发创新能力，研发中心在研项目涉及抗风湿、免疫调节、抗结核、肿瘤、感染、心脑血管等疾病领域。2、三生制药1类小分子新药申报临床2月21日，据CDE官网显示，三生制药1类新药SSS39注射剂的临床试验申请获得受理。据三生制药公开资料显示，SSS39注射剂是雷帕霉素纳米粒，应用于自免、眼科及其他领域，目前具体适应症尚未公开。雷帕霉素是一种新型大环内酯类免疫抑制剂，早期被作为低毒性的抗真菌药物研究，后被发现具有免疫抑制等作用。1999年，FDA批准雷帕霉素上市，作为免疫抑制剂用于减轻肾移植后的抗排异反应。近年来，随着对雷帕霉素深入研究，其在抗癌、神经保护、改善神经退行性疾病甚至抗衰老等方面的潜力被不断发现。3、阿斯利康PD-1/CTLA-4双抗在国内申报临床2月21日，阿斯利康的PD-1/CTLA-4双抗MEDI5752的临床试验申请已获受理。MEDI5752是一种由CTLA-4单抗Tremelimumab与一种PD-1单抗组合而成的单价双抗，相比二价双抗不会引起受体同二聚化，靶向性更强。Tremelimumab已于今年10月获FDA批准上市，用于与度伐利尤单抗联用一线治疗肝癌。截至目前，全球仅1款PD-1/CTLA-4双抗上市，即康方生物的卡度尼利单抗；1款双抗产品（PSB205，齐鲁制药）已进入III期临床阶段。此外，默克的联合疗法（帕博利珠单抗+quavonlimab）也已进入III期临床阶段。4、安进AMG 451的临床试验申请获得受理2月21日，CDE显示，安进（Amgen）1类新药AMG 451的临床试验申请获得受理。AMG 451是一种潜在“first-in-class”全人源化抗OX40单克隆抗体，目前安进正在进行治疗特应性皮炎的III期临床研究。2021年6月，安进与协和麒麟达成合作，共同开发和商业化AMG 451。根据协议条款，安进以 4 亿美元首付款和 8.5 亿美元的里程碑付款获得了AMG 451在除日本外全球所有市场的开发、生产和商业化权益。编辑：淑文","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2413443984"}